{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:30:18Z","timestamp":1776400218581,"version":"3.51.2"},"reference-count":19,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,5,9]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Anticoagulation continuation vs cessation during thrombocytopenia did not affect recurrent thrombosis or bleeding after autologous HCT. Among anticoagulated patients undergoing autologous HCT, higher platelet counts were not associated with a lower risk of bleeding.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017006130","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T00:30:20Z","timestamp":1493339420000},"page":"707-714","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":23,"title":["Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation"],"prefix":"10.1182","volume":"1","author":[{"given":"Ang","family":"Li","sequence":"first","affiliation":[{"name":"Division of Hematology, University of Washington School of Medicine, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Davis","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Washington, Seattle, WA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline F.","family":"Kesten","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona A.","family":"Holmberg","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay K.","family":"Gopal","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Garcia","sequence":"additional","affiliation":[{"name":"Division of Hematology, University of Washington School of Medicine, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"issue":"7","key":"2019111616240891600_B1","doi-asserted-by":"crossref","first-page":"e1001275","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Horsted","year":"2012","journal-title":"PLoS Med"},{"issue":"9","key":"2019111616240891600_B2","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00277-016-2673-3","article-title":"Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis","volume":"95","author":"Zahid","year":"2016","journal-title":"Ann Hematol"},{"issue":"3","key":"2019111616240891600_B3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood-2007-10-117051","article-title":"The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention","volume":"112","author":"Gerber","year":"2008","journal-title":"Blood"},{"issue":"9","key":"2019111616240891600_B4","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jth.12338","article-title":"Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH","volume":"11","author":"Carrier","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"14","key":"2019111616240891600_B5","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2013-04-460162","article-title":"Treatment of cancer-associated thrombosis","volume":"122","author":"Lee","year":"2013","journal-title":"Blood"},{"issue":"17","key":"2019111616240891600_B6","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Lyman","year":"2013","journal-title":"J Clin Oncol"},{"key":"2019111616240891600_B7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.thromres.2016.03.011","article-title":"Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia","volume":"141","author":"Samuelson","year":"2016","journal-title":"Thromb Res"},{"issue":"2","key":"2019111616240891600_B8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00277-014-2198-6","article-title":"Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study","volume":"94","author":"Kopolovic","year":"2015","journal-title":"Ann Hematol"},{"issue":"8","key":"2019111616240891600_B9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/1076029614543140","article-title":"Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization","volume":"20","author":"Babilonia","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"issue":"11","key":"2019111616240891600_B10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.bmt.1704952","article-title":"Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature","volume":"35","author":"Ibrahim","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2019111616240891600_B11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111616240891600_B12","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1182\/blood-2014-08-551879","article-title":"How I treat incidental pulmonary embolism","volume":"125","author":"O\u2019Connell","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2019111616240891600_B13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.9243","article-title":"Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial","volume":"314","author":"Lee","year":"2015","journal-title":"JAMA"},{"issue":"9","key":"2019111616240891600_B14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1538-7836.2008.03077.x","article-title":"Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation","volume":"6","author":"Gonsalves","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111616240891600_B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MJT.0b013e31829b59f5","article-title":"Incidence of venous thromboembolism in the setting of hematopoietic cell transplantation","volume":"21","author":"O\u2019Hara","year":"2014","journal-title":"Am J Ther"},{"issue":"19","key":"2019111616240891600_B16","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111616240891600_B17","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/1097-0142(19921001)70:7<1895::AID-CNCR2820700715>3.0.CO;2-I","article-title":"Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation","volume":"70","author":"Drakos","year":"1992","journal-title":"Cancer"},{"issue":"26","key":"2019111616240891600_B18","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1182\/blood-2010-01-258624","article-title":"Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events","volume":"115","author":"Caruso","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111616240891600_B19","first-page":"844","article-title":"MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs","volume":"110","author":"Leleu","year":"2013","journal-title":"Thromb Haemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/12\/707\/877169\/advances006130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/12\/707\/877169\/advances006130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T21:24:25Z","timestamp":1573939465000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/12\/707\/16006\/Management-of-venous-thromboembolism-during"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,5,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017006130","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}